U.S. flag

An official website of the United States government

GTR Home > Tests > ColoGene

Indication

This is a clinical test intended for Help: Risk Assessment

Clinical summary

Help

Check Clinical features section (below), Conditions for which test is offered (above), and links on the right for additional information about this condition.

Conditions tested

Target population

Help

Individuals that meet NCCN criteria for Hereditary Gastrointestinal Cancer

Citations

  • ' ACOG Committee Opinion. Hereditary Cancer Syndromes and Risk Assessment. Committee on Genetics, Number 634, June 2015. Reaffirmed 2017.
  • ' ACOG Committee Opinion. Hereditary Cancer Syndromes and Risk Assessment. Committee on Genetics, Number 634, June 2015. Reaffirmed 2017. '
  • ' NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®). Genetic/Familial High-Risk Assesssment: Colorectal. Version 1.2018 - July 12, 2018. NCCN.org '
  • NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®). Genetic/Familial High-Risk Assesssment: Breast and Ovarian. Version 1.2019 - July 11, 2018. NCCN.org '

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

Clinical resources

Practice guidelines

  • NICE, 2021
    UK NICE Guideline NG151, Colorectal cancer, 2021

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.